The purpose of this study is to elucidate optimal dosing for High Intensity Gait Training (HIGT) to reduce locomotor disability for those undergoing inpatient rehabilitation (IR) in the subacute phase of stroke recovery.
This is a randomized controlled trial conducted at a single IR facility. Investigators will randomize patients to receive one of two distinct HIGT interventions or a high step count intervention during standard care.
None
Weightbearing restrictions, uncontrolled cardiopulmonary, metabolic, infectious, or psychiatric disorders, which would preclude aerobic locomotor training
Estimated length of stay of less than 14 days
Non-ambulatory status prior to admission (unable to walk >50 meters)
Pregnant
NYU Langone Health
Lead sponsor
National Institutes of Health (NIH)
Collaborator